Full-Life Technologies Launches with $10M Seed Round Financing to Advance Its Nuclear Technology & Nuclear Medicines Businesses
Nuclear Medicine has seen a renaissance in recent years with significant clinical and commercial validation in some of the most challenging cancers.
